Freeline Therapeutics Holdings plc

06/14/2022 | Press release | Distributed by Public on 06/14/2022 05:02

Freeline Initiates Dosing of Second Cohort in B-LIEVE Dose Confirmation Trial of FLT180a in Hemophilia B - Form 6-K